Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03938987 |
Title | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3zeta) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) (ACIT001/EXC002) |
Acronym | ACIT001/EXC002 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | University of Alberta |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Foothills Medical Centre | NOT_YET_RECRUITING | Calgary | Alberta | T2N2T9 | Canada | Details |
Tom Baker Cancer Centre | NOT_YET_RECRUITING | Calgary | Alberta | T2N4N2 | Canada | Details |
Alberta Children's Hospital | NOT_YET_RECRUITING | Calgary | Alberta | T3B6A8 | Canada | Details |
Cross Cancer Institute | RECRUITING | Edmonton | Alberta | T6G1Z2 | Canada | Details |
Stollery Children's Hospital | NOT_YET_RECRUITING | Edmonton | Alberta | T6G2B7 | Canada | Details |
University of Alberta Hospital | RECRUITING | Edmonton | Alberta | T6G2B7 | Canada | Details |